efaroxan has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adorjan, I; Bauer, L; Belz, M; Brunmair, B; de Cillia, VA; Fenzl, A; Frobel, K; Fürnsinn, C; Gruber, D; Lehner, Z; Luger, A; Rustenbeck, I; Stadlbauer, K | 1 |
| Abdel-Zaher, AO; Ahmed, IT; El-Koussi, AD | 1 |
2 other study(ies) available for efaroxan and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Brimonidine Tartrate; Calcium; Cells, Cultured; Diabetes Mellitus, Type 2; Diazoxide; Female; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; KATP Channels; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Quinoxalines; Yohimbine | 2012 |
The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Male; Rabbits; Rats; Rats, Wistar; Vasodilation; Yohimbine | 2001 |